Antibody-drug Conjugates Market - Global Outlook and Forecast 2021-2027

March 2021 | 90 pages | ID: AD7FA2796E65EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Antibody-drug Conjugates in global, including the following market information:

Global Antibody-drug Conjugates Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global Antibody-drug Conjugates Market Sales, 2016-2021, 2022-2027, (Kg)

Global top five Antibody-drug Conjugates companies in 2020 (%)

The global Antibody-drug Conjugates market was valued at 2813.5 million in 2020 and is projected to reach US$ 3354.9 million by 2027, at a CAGR of 4.5% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antibody-drug Conjugates manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antibody-drug Conjugates Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Kg)

Global Antibody-drug Conjugates Market Segment Percentages, By Type, 2020 (%)

• Adcetris
• Kadcyla

Global Antibody-drug Conjugates Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (Kg)

Global Antibody-drug Conjugates Market Segment Percentages, By Application, 2020 (%)

• Breast Cancer
• Lymphoma

Global Antibody-drug Conjugates Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (Kg)

Global Antibody-drug Conjugates Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Antibody-drug Conjugates revenues in global market, 2016-2021 (Estimated), ($ millions)

Key companies Antibody-drug Conjugates revenues share in global market, 2020 (%)

Key companies Antibody-drug Conjugates sales in global market, 2016-2021 (Estimated), (Kg)

Key companies Antibody-drug Conjugates sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

• ImmunoGen
• Seattle Genetics
• Roche
• Takeda

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Antibody-drug Conjugates Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Antibody-drug Conjugates Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTIBODY-DRUG CONJUGATES OVERALL MARKET SIZE

2.1 Global Antibody-drug Conjugates Market Size: 2021 VS 2027
2.2 Global Antibody-drug Conjugates Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Antibody-drug Conjugates Sales (Consumption): 2016-2027

3 COMPANY LANDSCAPE

3.1 Top Antibody-drug Conjugates Players in Global Market
3.2 Top Global Antibody-drug Conjugates Companies Ranked by Revenue
3.3 Global Antibody-drug Conjugates Revenue by Companies
3.4 Global Antibody-drug Conjugates Sales by Companies
3.5 Global Antibody-drug Conjugates Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Antibody-drug Conjugates Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Antibody-drug Conjugates Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antibody-drug Conjugates Players in Global Market
  3.8.1 List of Global Tier 1 Antibody-drug Conjugates Companies
  3.8.2 List of Global Tier 2 and Tier 3 Antibody-drug Conjugates Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Antibody-drug Conjugates Market Size Markets, 2021 & 2027
  4.1.2 Adcetris
  4.1.3 Kadcyla
4.2 By Type - Global Antibody-drug Conjugates Revenue & Forecasts
  4.2.1 By Type - Global Antibody-drug Conjugates Revenue, 2016-2021
  4.2.2 By Type - Global Antibody-drug Conjugates Revenue, 2022-2027
  4.2.3 By Type - Global Antibody-drug Conjugates Revenue Market Share, 2016-2027
4.3 By Type - Global Antibody-drug Conjugates Sales & Forecasts
  4.3.1 By Type - Global Antibody-drug Conjugates Sales, 2016-2021
  4.3.2 By Type - Global Antibody-drug Conjugates Sales, 2022-2027
  4.3.3 By Type - Global Antibody-drug Conjugates Sales Market Share, 2016-2027
4.4 By Type - Global Antibody-drug Conjugates Price (Manufacturers Selling Prices), 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Antibody-drug Conjugates Market Size, 2021 & 2027
  5.1.2 Breast Cancer
  5.1.3 Lymphoma
5.2 By Application - Global Antibody-drug Conjugates Revenue & Forecasts
  5.2.1 By Application - Global Antibody-drug Conjugates Revenue, 2016-2021
  5.2.2 By Application - Global Antibody-drug Conjugates Revenue, 2022-2027
  5.2.3 By Application - Global Antibody-drug Conjugates Revenue Market Share, 2016-2027
5.3 By Application - Global Antibody-drug Conjugates Sales & Forecasts
  5.3.1 By Application - Global Antibody-drug Conjugates Sales, 2016-2021
  5.3.2 By Application - Global Antibody-drug Conjugates Sales, 2022-2027
  5.3.3 By Application - Global Antibody-drug Conjugates Sales Market Share, 2016-2027
5.4 By Application - Global Antibody-drug Conjugates Price (Manufacturers Selling Prices), 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Antibody-drug Conjugates Market Size, 2021 & 2027
6.2 By Region - Global Antibody-drug Conjugates Revenue & Forecasts
  6.2.1 By Region - Global Antibody-drug Conjugates Revenue, 2016-2021
  6.2.2 By Region - Global Antibody-drug Conjugates Revenue, 2022-2027
  6.2.3 By Region - Global Antibody-drug Conjugates Revenue Market Share, 2016-2027
6.3 By Region - Global Antibody-drug Conjugates Sales & Forecasts
  6.3.1 By Region - Global Antibody-drug Conjugates Sales, 2016-2021
  6.3.2 By Region - Global Antibody-drug Conjugates Sales, 2022-2027
  6.3.3 By Region - Global Antibody-drug Conjugates Sales Market Share, 2016-2027
6.4 North America
  6.4.1 By Country - North America Antibody-drug Conjugates Revenue, 2016-2027
  6.4.2 By Country - North America Antibody-drug Conjugates Sales, 2016-2027
  6.4.3 US Antibody-drug Conjugates Market Size, 2016-2027
  6.4.4 Canada Antibody-drug Conjugates Market Size, 2016-2027
  6.4.5 Mexico Antibody-drug Conjugates Market Size, 2016-2027
6.5 Europe
  6.5.1 By Country - Europe Antibody-drug Conjugates Revenue, 2016-2027
  6.5.2 By Country - Europe Antibody-drug Conjugates Sales, 2016-2027
  6.5.3 Germany Antibody-drug Conjugates Market Size, 2016-2027
  6.5.4 France Antibody-drug Conjugates Market Size, 2016-2027
  6.5.5 U.K. Antibody-drug Conjugates Market Size, 2016-2027
  6.5.6 Italy Antibody-drug Conjugates Market Size, 2016-2027
  6.5.7 Russia Antibody-drug Conjugates Market Size, 2016-2027
  6.5.8 Nordic Countries Antibody-drug Conjugates Market Size, 2016-2027
  6.5.9 Benelux Antibody-drug Conjugates Market Size, 2016-2027
6.6 Asia
  6.6.1 By Region - Asia Antibody-drug Conjugates Revenue, 2016-2027
  6.6.2 By Region - Asia Antibody-drug Conjugates Sales, 2016-2027
  6.6.3 China Antibody-drug Conjugates Market Size, 2016-2027
  6.6.4 Japan Antibody-drug Conjugates Market Size, 2016-2027
  6.6.5 South Korea Antibody-drug Conjugates Market Size, 2016-2027
  6.6.6 Southeast Asia Antibody-drug Conjugates Market Size, 2016-2027
  6.6.7 India Antibody-drug Conjugates Market Size, 2016-2027
6.7 South America
  6.7.1 By Country - South America Antibody-drug Conjugates Revenue, 2016-2027
  6.7.2 By Country - South America Antibody-drug Conjugates Sales, 2016-2027
  6.7.3 Brazil Antibody-drug Conjugates Market Size, 2016-2027
  6.7.4 Argentina Antibody-drug Conjugates Market Size, 2016-2027
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Antibody-drug Conjugates Revenue, 2016-2027
  6.8.2 By Country - Middle East & Africa Antibody-drug Conjugates Sales, 2016-2027
  6.8.3 Turkey Antibody-drug Conjugates Market Size, 2016-2027
  6.8.4 Israel Antibody-drug Conjugates Market Size, 2016-2027
  6.8.5 Saudi Arabia Antibody-drug Conjugates Market Size, 2016-2027
  6.8.6 UAE Antibody-drug Conjugates Market Size, 2016-2027

7 MANUFACTURERS & BRANDS PROFILES

7.1 ImmunoGen
  7.1.1 ImmunoGen Corporate Summary
  7.1.2 ImmunoGen Business Overview
  7.1.3 ImmunoGen Antibody-drug Conjugates Major Product Offerings
  7.1.4 ImmunoGen Antibody-drug Conjugates Sales and Revenue in Global (2016-2021)
  7.1.5 ImmunoGen Key News
7.2 Seattle Genetics
  7.2.1 Seattle Genetics Corporate Summary
  7.2.2 Seattle Genetics Business Overview
  7.2.3 Seattle Genetics Antibody-drug Conjugates Major Product Offerings
  7.2.4 Seattle Genetics Antibody-drug Conjugates Sales and Revenue in Global (2016-2021)
  7.2.5 Seattle Genetics Key News
7.3 Roche
  7.3.1 Roche Corporate Summary
  7.3.2 Roche Business Overview
  7.3.3 Roche Antibody-drug Conjugates Major Product Offerings
  7.3.4 Roche Antibody-drug Conjugates Sales and Revenue in Global (2016-2021)
  7.3.5 Roche Key News
7.4 Takeda
  7.4.1 Takeda Corporate Summary
  7.4.2 Takeda Business Overview
  7.4.3 Takeda Antibody-drug Conjugates Major Product Offerings
  7.4.4 Takeda Antibody-drug Conjugates Sales and Revenue in Global (2016-2021)
  7.4.5 Takeda Key News

8 GLOBAL ANTIBODY-DRUG CONJUGATES PRODUCTION CAPACITY, ANALYSIS

8.1 Global Antibody-drug Conjugates Production Capacity, 2016-2027
8.2 Antibody-drug Conjugates Production Capacity of Key Manufacturers in Global Market
8.3 Global Antibody-drug Conjugates Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 ANTIBODY-DRUG CONJUGATES SUPPLY CHAIN ANALYSIS

10.1 Antibody-drug Conjugates Industry Value Chain
10.2 Antibody-drug Conjugates Upstream Market
10.3 Antibody-drug Conjugates Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Antibody-drug Conjugates Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Antibody-drug Conjugates in Global Market
Table 2. Top Antibody-drug Conjugates Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Antibody-drug Conjugates Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Antibody-drug Conjugates Revenue Share by Companies, 2016-2021
Table 5. Global Antibody-drug Conjugates Sales by Companies, (Kg), 2016-2021
Table 6. Global Antibody-drug Conjugates Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Antibody-drug Conjugates Price (2016-2021) & (USD/Kg)
Table 8. Global Manufacturers Antibody-drug Conjugates Product Type
Table 9. List of Global Tier 1 Antibody-drug Conjugates Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antibody-drug Conjugates Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Antibody-drug Conjugates Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Antibody-drug Conjugates Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Antibody-drug Conjugates Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Antibody-drug Conjugates Sales (Kg), 2016-2021
Table 15. By Type - Global Antibody-drug Conjugates Sales (Kg), 2022-2027
Table 16. By Application – Global Antibody-drug Conjugates Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Antibody-drug Conjugates Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Antibody-drug Conjugates Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Antibody-drug Conjugates Sales (Kg), 2016-2021
Table 20. By Application - Global Antibody-drug Conjugates Sales (Kg), 2022-2027
Table 21. By Region – Global Antibody-drug Conjugates Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Antibody-drug Conjugates Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Antibody-drug Conjugates Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Antibody-drug Conjugates Sales (Kg), 2016-2021
Table 25. By Region - Global Antibody-drug Conjugates Sales (Kg), 2022-2027
Table 26. By Country - North America Antibody-drug Conjugates Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Antibody-drug Conjugates Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Antibody-drug Conjugates Sales, (Kg), 2016-2021
Table 29. By Country - North America Antibody-drug Conjugates Sales, (Kg), 2022-2027
Table 30. By Country - Europe Antibody-drug Conjugates Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Antibody-drug Conjugates Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Antibody-drug Conjugates Sales, (Kg), 2016-2021
Table 33. By Country - Europe Antibody-drug Conjugates Sales, (Kg), 2022-2027
Table 34. By Region - Asia Antibody-drug Conjugates Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Antibody-drug Conjugates Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Antibody-drug Conjugates Sales, (Kg), 2016-2021
Table 37. By Region - Asia Antibody-drug Conjugates Sales, (Kg), 2022-2027
Table 38. By Country - South America Antibody-drug Conjugates Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Antibody-drug Conjugates Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Antibody-drug Conjugates Sales, (Kg), 2016-2021
Table 41. By Country - South America Antibody-drug Conjugates Sales, (Kg), 2022-2027
Table 42. By Country - Middle East & Africa Antibody-drug Conjugates Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Antibody-drug Conjugates Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Antibody-drug Conjugates Sales, (Kg), 2016-2021
Table 45. By Country - Middle East & Africa Antibody-drug Conjugates Sales, (Kg), 2022-2027
Table 46. ImmunoGen Corporate Summary
Table 47. ImmunoGen Antibody-drug Conjugates Product Offerings
Table 48. ImmunoGen Antibody-drug Conjugates Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 49. Seattle Genetics Corporate Summary
Table 50. Seattle Genetics Antibody-drug Conjugates Product Offerings
Table 51. Seattle Genetics Antibody-drug Conjugates Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 52. Roche Corporate Summary
Table 53. Roche Antibody-drug Conjugates Product Offerings
Table 54. Roche Antibody-drug Conjugates Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 55. Takeda Corporate Summary
Table 56. Takeda Antibody-drug Conjugates Product Offerings
Table 57. Takeda Antibody-drug Conjugates Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 58. Antibody-drug Conjugates Production Capacity (Kg) of Key Manufacturers in Global Market, 2019-2021 (Kg)
Table 59. Global Antibody-drug Conjugates Capacity Market Share of Key Manufacturers, 2019-2021
Table 60. Global Antibody-drug Conjugates Production by Region, 2016-2021 (Kg)
Table 61. Global Antibody-drug Conjugates Production by Region, 2022-2027 (Kg)
Table 62. Antibody-drug Conjugates Market Opportunities & Trends in Global Market
Table 63. Antibody-drug Conjugates Market Drivers in Global Market
Table 64. Antibody-drug Conjugates Market Restraints in Global Market
Table 65. Antibody-drug Conjugates Raw Materials
Table 66. Antibody-drug Conjugates Raw Materials Suppliers in Global Market
Table 67. Typical Antibody-drug Conjugates Downstream
Table 68. Antibody-drug Conjugates Downstream Clients in Global Market
Table 69. Antibody-drug Conjugates Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Antibody-drug Conjugates Segment by Type
Figure 2. Antibody-drug Conjugates Segment by Application
Figure 3. Global Antibody-drug Conjugates Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Antibody-drug Conjugates Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Antibody-drug Conjugates Revenue, 2016-2027 (US$, Mn)
Figure 7. Antibody-drug Conjugates Sales in Global Market: 2016-2027 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Antibody-drug Conjugates Revenue in 2020
Figure 9. By Type - Global Antibody-drug Conjugates Sales Market Share, 2016-2027
Figure 10. By Type - Global Antibody-drug Conjugates Revenue Market Share, 2016-2027
Figure 11. By Type - Global Antibody-drug Conjugates Price (USD/Kg), 2016-2027
Figure 12. By Application - Global Antibody-drug Conjugates Sales Market Share, 2016-2027
Figure 13. By Application - Global Antibody-drug Conjugates Revenue Market Share, 2016-2027
Figure 14. By Application - Global Antibody-drug Conjugates Price (USD/Kg), 2016-2027
Figure 15. By Region - Global Antibody-drug Conjugates Sales Market Share, 2016-2027
Figure 16. By Region - Global Antibody-drug Conjugates Revenue Market Share, 2016-2027
Figure 17. By Country - North America Antibody-drug Conjugates Revenue Market Share, 2016-2027
Figure 18. By Country - North America Antibody-drug Conjugates Sales Market Share, 2016-2027
Figure 19. US Antibody-drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Antibody-drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Antibody-drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Antibody-drug Conjugates Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Antibody-drug Conjugates Sales Market Share, 2016-2027
Figure 24. Germany Antibody-drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 25. France Antibody-drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Antibody-drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Antibody-drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Antibody-drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Antibody-drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Antibody-drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Antibody-drug Conjugates Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Antibody-drug Conjugates Sales Market Share, 2016-2027
Figure 33. China Antibody-drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Antibody-drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Antibody-drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Antibody-drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 37. India Antibody-drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Antibody-drug Conjugates Revenue Market Share, 2016-2027
Figure 39. By Country - South America Antibody-drug Conjugates Sales Market Share, 2016-2027
Figure 40. Brazil Antibody-drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Antibody-drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Antibody-drug Conjugates Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Antibody-drug Conjugates Sales Market Share, 2016-2027
Figure 44. Turkey Antibody-drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Antibody-drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Antibody-drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Antibody-drug Conjugates Revenue, (US$, Mn), 2016-2027
Figure 48. Global Antibody-drug Conjugates Production Capacity (Kg), 2016-2027
Figure 49. The Percentage of Production Antibody-drug Conjugates by Region, 2020 VS 2027
Figure 50. Antibody-drug Conjugates Industry Value Chain
Figure 51. Marketing Channels